Corvus Pharmaceuticals, Inc. (CRVS) Earnings
NASDAQ·Healthcare·Biotechnology
$12.98
+0.23%
Mkt Cap $1.17B
EPS — Estimate vs Actual
Mkt Cap
$1.17B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55
NASDAQ·Healthcare·Biotechnology
$12.98
+0.23%
Mkt Cap $1.17B
Mkt Cap
$1.17B
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$0.55